Loading...
Home2024-06-10T14:38:33-04:00

To patients, the only ones that matter, we are Trusted Quality Care

For the over 700,000 Canadians that benefit from radiopharmaceuticals annually, their last concern should be the veracity of these crucial medicines brought to bear during their treatment. We will do everything in our power to provide a consistent supply of the highest quality radiopharmaceuticals in the world and deliver them on time. We currently deliver 99.6% certainty. Good, but we can do better because ultimately we’re here to be your Trusted Quality Care Partner.

Our approach

Spect Radiopharmaceuticals

0
DOSES PREPARED AND DISTRIBUTED DAILY
0
HOSPITALS AND CLINICS ACROSS CANADA
0
CONTAINERS SHIPPED ANNUALLY

André Gagnon, President

ISOLOGIC has taken a leadership position in supplying the Canadian nuclear medicine community with clinically relevant radiopharmaceuticals. Our proven success in developing and commercializing innovative imaging agents provides strong evidence of our willingness to bring forward breakthrough radiopharmaceuticals to market.

With state-of-the-art facilities across Central Canada, and strategic alliances with world-renowned university research hospitals and dedicated expert resources, ISOLOGIC is ready to expand its offering to include the next generation of PET and SPECT compounds and provide nuclear medicine centers with the most significant tools to improve patient care.

Management team

David Paradis

Vice-President Finance

Christine Henault

Vice-President Sales and Marketing

Annette Proulx

Vice-President of Operations

Frank Maiorino

Vice-President Business Development

Jeanne Yaourtsakis

Vice-President Human Ressources

Stephane Martin

Sr. Director of CMC / Quality & New Products Development

Vasa Sindolic

Senior Director Cyclotron and Engineering

Noteworthy News

News, Insight, Education

Go to Top